Inhibition of NFATc3 activation by a novel cell-permeable calcineurin peptide inhibitor CNI103 mitigated the development of acute lung injury (ALI) in LPS-treated mice. The gene discussed is NFATC3; the disease is acute respiratory distress syndrome.